CGT Catapult teams with TrakCel for cell and gene therapy tracking 08-Sep-2017 By Gareth Macdonald Firms that make therapies at the Cell and Gene Therapy Catapult facility in Stevenage, UK will track their products using tech provided by TrakCel.
Cell and gene therapy investment to continue to grow post-Brexit, CGT Catapult 21-Sep-2016 By Dan Stanton Brexit will not stifle interest in the UK’s cell and gene therapy space, says the CGT Catapult which has reported a tenfold growth in investment since 2012 to £400m ($520m).